Pharmacogenetics: Genetic approach supports cardiovascular safety of GLP1R agonists.

Fernández-Ruiz, Irene

Pharmacogenetics: Genetic approach supports cardiovascular safety of GLP1R agonists. [electronic resource] - Nature reviews. Cardiology 08 2016 - 444 p. digital

Publication Type: Journal Article

1759-5010

10.1038/nrcardio.2016.100 doi


Coronary Disease--chemically induced
Glucagon-Like Peptide-1 Receptor--genetics
Humans
Hypoglycemic Agents--adverse effects
Pharmacogenetics
Pharmacogenomic Variants
Protective Factors
Risk Assessment
Risk Factors
Glucagon-Like Peptide-1 Receptor Agonists